TLPH Talphera Inc.

Price (delayed)

$1.5

Market cap

$25.43M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.98

Enterprise value

$12.04M

acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known ...

Highlights
The quick ratio has surged by 174% year-on-year and by 113% since the previous quarter
TLPH's gross profit has soared by 121% YoY and by 82% QoQ
TLPH's EPS has dropped by 157% year-on-year but it is up by 22% since the previous quarter
TLPH's net income has plunged by 145% YoY but it is up by 20% from the previous quarter

Key stats

What are the main financial stats of TLPH
Market
Shares outstanding
16.95M
Market cap
$25.43M
Enterprise value
$12.04M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.34
Price to sales (P/S)
40.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
19.36
Earnings
Revenue
$622,000
EBIT
-$20.6M
EBITDA
-$19.94M
Free cash flow
-$19.1M
Per share
EPS
-$2.98
Free cash flow per share
-$1.14
Book value per share
$1.12
Revenue per share
$0.04
TBVPS
$1.39
Balance sheet
Total assets
$23.26M
Total liabilities
$4.95M
Debt
$0
Equity
$18.31M
Working capital
$10.85M
Liquidity
Debt to equity
0
Current ratio
4.04
Quick ratio
3.75
Net debt/EBITDA
0.67
Margins
EBITDA margin
-3,206.3%
Gross margin
41.8%
Net margin
-3,434.7%
Operating margin
-3,221.7%
Efficiency
Return on assets
-92.3%
Return on equity
-163.5%
Return on invested capital
-216.6%
Return on capital employed
-104.6%
Return on sales
-3,311.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TLPH stock price

How has the Talphera stock price performed over time
Intraday
2.04%
1 week
20%
1 month
45.63%
1 year
7.91%
YTD
104.08%
QTD
104.08%

Financial performance

How have Talphera's revenue and profit performed over time
Revenue
$622,000
Gross profit
$260,000
Operating income
-$20.04M
Net income
-$21.36M
Gross margin
41.8%
Net margin
-3,434.7%
TLPH's net income has plunged by 145% YoY but it is up by 20% from the previous quarter
TLPH's gross profit has soared by 121% YoY and by 82% QoQ
TLPH's operating margin has soared by 100% YoY and by 23% QoQ
Talphera's net margin has plunged by 100% YoY but it has increased by 35% from the previous quarter

Growth

What is Talphera's growth rate over time

Valuation

What is Talphera stock price valuation
P/E
N/A
P/B
1.34
P/S
40.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
19.36
TLPH's EPS has dropped by 157% year-on-year but it is up by 22% since the previous quarter
The P/B is 87% more than the last 4 quarters average of 0.7
TLPH's equity has soared by 76% from the previous quarter but it is down by 33% YoY
TLPH's price to sales (P/S) is 104% higher than its last 4 quarters average of 19.4 but 95% lower than its 5-year quarterly average of 850.2
TLPH's revenue is up by 23% QoQ

Efficiency

How efficient is Talphera business performance
TLPH's return on sales has dropped by 100% year-on-year but it is up by 35% since the previous quarter
The company's return on invested capital fell by 24% QoQ
The company's return on equity rose by 6% QoQ

Dividends

What is TLPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TLPH.

Financial health

How did Talphera financials performed over time
The quick ratio has surged by 174% year-on-year and by 113% since the previous quarter
The company's current ratio has surged by 157% YoY and by 93% QoQ
Talphera's debt is 100% less than its equity
Talphera's debt has plunged by 100% YoY
The debt to equity has plunged by 100% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.